MedPath

GlideScope® vs GlideScope® + aScope® for Managing Difficult Airways.

Not Applicable
Conditions
Airway Morbidity
Anesthesia Intubation Complication
Interventions
Device: aScope®
Device: Glidescope®
Registration Number
NCT02627755
Lead Sponsor
Hospital de Manises
Brief Summary

The use in a combined way of two systems of intubation (Glidescope + aScope) would condition an increase in the success rate of endotracheal intubation maneuver compared to conventional isolated Glidescope use in patients with clinical criteria of difficult airway.

Detailed Description

Worldwide, up to 600 patients are estimated to die annually as a result of the complications that occur during tracheal intubation The GlideScope® (videolaryngoscope) is used for endotracheal intubation in patients with difficult airway predictors, in this patients overall success intubation rate is 96%. but success intubation rate at first attempt is only 86%.

Despite this positive rates, due to high comorbidity when intubation fails, both failure rates (inverse of success rate) are impermissible. 14% failure at the first attempt intubation as well as 4% overall intubation failure.

in this study the investigators try to show that new procedure associating aScope® (disposable fiberscope) together with GlideScope® increases the success intubation rate of both ( overall and first attempt).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Patients programed for general anesthesia with endotracheal intubation required that presents one or both criteria of difficult airway predictors:
  • criteria 1: Arne test >10 (Arne J,1998)
  • criteria 2: Ratio between neck circumference and thyromental distance > 4. (Kim WH, 2011)
Exclusion Criteria
  • Patients with mouth opening which does not allow the introduction of video laryngoscope.
  • Patients with indication of flexible fiberoptic intubation with awake patient.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Glide+aScope groupaScope®Device: combined use of two airway devices Glidescope® + aScope®
Glide groupGlidescope®Device: Glidescope® use
Glide+aScope groupGlidescope®Device: combined use of two airway devices Glidescope® + aScope®
Primary Outcome Measures
NameTimeMethod
first attempt intubation success ratethrough study completion, an average of 1 year.

first attempt intubation success rate

Secondary Outcome Measures
NameTimeMethod
overall intubation success ratethrough study completion, an average of 1 year.

through study completion, an average of 1 year.

intubation time (in seconds)through study completion, an average of 1 year

during anesthetic induction time until inflate pneumo tamponade after tracheal intubation

complications related to intubation30 days postoperative

questionnaire

Trial Locations

Locations (1)

Hospital de Manises

🇪🇸

Manises, Valencia, Spain

© Copyright 2025. All Rights Reserved by MedPath